BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsieh TJ, Fustier P, Wei CC, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS. Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J Endocrinol. 2004;183:535-550. [PMID: 15590980 DOI: 10.1677/joe.1.05871] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Tran S, Chen YW, Chenier I, Chan JS, Quaggin S, Hébert MJ, Ingelfinger JR, Zhang SL. Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol 2008;19:943-52. [PMID: 18305124 DOI: 10.1681/ASN.2007080864] [Cited by in Crossref: 78] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
2 Yanofsky SM, Dugas CM, Katsurada A, Liu J, Saifudeen Z, El-Dahr SS, Satou R. Angiotensin II biphasically regulates cell differentiation in human iPSC-derived kidney organoids. Am J Physiol Renal Physiol 2021;321:F559-71. [PMID: 34448643 DOI: 10.1152/ajprenal.00134.2021] [Reference Citation Analysis]
3 Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, Zhang SL, Guo DF, Filep JG, Ingelfinger JR, Chan JS. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 2007;71:912-23. [PMID: 17342175 DOI: 10.1038/sj.ki.5002188] [Cited by in Crossref: 124] [Cited by in F6Publishing: 111] [Article Influence: 8.9] [Reference Citation Analysis]
4 Brezniceanu ML, Lau CJ, Godin N, Chénier I, Duclos A, Ethier J, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J Am Soc Nephrol. 2010;21:943-954. [PMID: 20299359 DOI: 10.1681/asn.2009030242] [Cited by in Crossref: 62] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
5 Wei Y, Sowers JR, Nistala R, Gong H, Uptergrove GM, Clark SE, Morris EM, Szary N, Manrique C, Stump CS. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem. 2006;281:35137-35146. [PMID: 16982630 DOI: 10.1074/jbc.m601320200] [Cited by in Crossref: 194] [Cited by in F6Publishing: 97] [Article Influence: 12.9] [Reference Citation Analysis]
6 Zhang SL, Chen YW, Tran S, Liu F, Nestoridi E, Hébert MJ, Ingelfinger JR. Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop. Pediatr Nephrol 2007;22:813-24. [PMID: 17357786 DOI: 10.1007/s00467-007-0444-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
7 Liu F, Wei C, Wu S, Chenier I, Zhang S, Filep JG, Ingelfinger JR, Chan JS. Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney International 2009;75:156-66. [DOI: 10.1038/ki.2008.509] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
8 Gonzalez-Villalobos RA, Satou R, Ohashi N, Semprun-Prieto LC, Katsurada A, Kim C, Upchurch GM, Prieto MC, Kobori H, Navar LG. Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol 2010;298:F150-7. [PMID: 19846570 DOI: 10.1152/ajprenal.00477.2009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
9 Rajapakse AG, Ming XF, Carvas JM, Yang Z. The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects.Am J Physiol Heart Circ Physiol. 2009;296:H815-H822. [PMID: 19136606 DOI: 10.1152/ajpheart.00756.2008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
10 Suzaki Y, Ozawa Y, Kobori H. Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int J Biol Sci 2006;3:40-6. [PMID: 17200690 DOI: 10.7150/ijbs.3.40] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
11 Ghosh A, Abdo S, Zhao S, Wu CH, Shi Y, Lo CS, Chenier I, Alquier T, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD. Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice. Endocrinology 2017;158:903-19. [PMID: 28324005 DOI: 10.1210/en.2016-1576] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
12 Chen YW, Liu F, Tran S, Zhu Y, Hébert MJ, Ingelfinger JR, Zhang SL. Reactive oxygen species and nuclear factor-kappa B pathway mediate high glucose-induced Pax-2 gene expression in mouse embryonic mesenchymal epithelial cells and kidney explants. Kidney Int 2006;70:1607-15. [PMID: 16985513 DOI: 10.1038/sj.ki.5001871] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
13 Woods TC, Satou R, Miyata K, Katsurada A, Dugas CM, Klingenberg NC, Fonseca VA, Navar LG. Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus. Am J Nephrol 2019;49:331-42. [PMID: 30921791 DOI: 10.1159/000499597] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
14 Avogaro A, de Kreutzenberg SV, Fadini GP. Insulin signaling and life span. Pflugers Arch - Eur J Physiol 2010;459:301-14. [DOI: 10.1007/s00424-009-0721-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
15 Marre M, Leye A. Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity. Diabetes and Vascular Disease Research 2007;4:163-73. [DOI: 10.3132/dvdr.2007.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
16 Miyata K, Ohashi N, Suzaki Y, Katsurada A, Kobori H. Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol 2008;35:922-7. [PMID: 18430060 DOI: 10.1111/j.1440-1681.2008.04938.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
17 Sachetelli S, Liu Q, Zhang S, Liu F, Hsieh T, Brezniceanu M, Guo D, Filep J, Ingelfinger J, Sigmund C, Hamet P, Chan J. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney International 2006;69:1016-23. [DOI: 10.1038/sj.ki.5000210] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 7.0] [Reference Citation Analysis]
18 Burns KD, Lytvyn Y, Mahmud FH, Daneman D, Deda L, Dunger DB, Deanfield J, Dalton RN, Elia Y, Har R, Van JA, Bradley TJ, Slorach C, Hui W, Xiao F, Zimpelmann J, Mertens L, Moineddin R, Reich HN, Sochett E, Scholey JW, Cherney DZI. The relationship between urinary renin-angiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetes. American Journal of Physiology-Renal Physiology 2017;312:F335-42. [DOI: 10.1152/ajprenal.00438.2016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
19 Ha H, Hwang IA, Park JH, Lee HB. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 2008;82 Suppl 1:S42-5. [PMID: 18845352 DOI: 10.1016/j.diabres.2008.09.017] [Cited by in Crossref: 148] [Cited by in F6Publishing: 137] [Article Influence: 11.4] [Reference Citation Analysis]
20 Garagliano JM, Katsurada A, Miyata K, Derbenev AV, Zsombok A, Navar LG, Satou R. Advanced Glycation End Products Stimulate Angiotensinogen Production in Renal Proximal Tubular Cells. Am J Med Sci 2019;357:57-66. [PMID: 30466736 DOI: 10.1016/j.amjms.2018.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Ichikawa D, Kamijo-ikemori A, Sugaya T, Shibagaki Y, Yasuda T, Hoshino S, Katayama K, Igarashi-migitaka J, Hirata K, Kimura K. Human liver-type fatty acid–binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury. American Journal of Physiology-Renal Physiology 2015;308:F114-21. [DOI: 10.1152/ajprenal.00469.2014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
22 Bosc LV, Resta T, Walker B, Kanagy NL. Mechanisms of intermittent hypoxia induced hypertension. J Cell Mol Med 2010;14:3-17. [PMID: 19818095 DOI: 10.1111/j.1582-4934.2009.00929.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
23 Fan YY, Kohno M, Nakano D, Ohsaki H, Kobori H, Suwarni D, Ohashi N, Hitomi H, Asanuma K, Noma T, Tomino Y, Fujita T, Nishiyama A. Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte. J Hypertens 2010;28:1034-43. [PMID: 20411599 DOI: 10.1097/hjh.0b013e328336ade3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
24 Polizio AH, Balestrasse KB, Gornalusse GG, Gorzalczany SB, Santa-cruz DM, Yannarelli GG, Peña C, Tomaro ML. Losartan exerts renoprotection through NAD(P)H oxidase downregulation in a renovascular model of hypertension. Regulatory Peptides 2009;156:28-33. [DOI: 10.1016/j.regpep.2009.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
25 Motawi TK, El-maraghy SA, Senousy MA. Angiotensin-Converting Enzyme Inhibition and Angiotensin AT1 Receptor Blockade Downregulate Angiotensin-Converting Enzyme Expression and Attenuate Renal Injury in Streptozotocin-Induced Diabetic Rats: RENOPROTECTION BY ACE DOWNREGULATION. J Biochem Mol Toxicol 2013;27:378-87. [DOI: 10.1002/jbt.21500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
26 Satou R, Cypress MW, Woods TC, Katsurada A, Dugas CM, Fonseca VA, Navar LG. Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells. Am J Physiol Renal Physiol 2020;318:F67-75. [PMID: 31682172 DOI: 10.1152/ajprenal.00402.2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
27 Reverte V, Gogulamudi VR, Rosales CB, Musial DC, Gonsalez SR, Parra-Vitela AJ, Galeas-Pena M, Sure VN, Visniauskas B, Lindsey SH, Katakam PVG, Prieto MC. Urinary angiotensinogen increases in the absence of overt renal injury in high fat diet-induced type 2 diabetic mice. J Diabetes Complications 2020;34:107448. [PMID: 31761419 DOI: 10.1016/j.jdiacomp.2019.107448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Aroor AR, Shukla SD. Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression. World J Hepatol 2011; 3(9): 250-255 [PMID: 21969878 DOI: 10.4254/wjh.v3.i9.250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Kamiyama M, Urushihara M, Morikawa T, Konishi Y, Imanishi M, Nishiyama A, Kobori H. Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy. Int J Mol Sci 2013;14:23045-62. [PMID: 24284398 DOI: 10.3390/ijms141123045] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
30 Zhang SL, Chen YW, Tran S, Chenier I, Hébert MJ, Ingelfinger JR. Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol 2007;18:2105-15. [PMID: 17538188 DOI: 10.1681/ASN.2006101124] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
31 Nistala R, Whaley-Connell A, Sowers JR. Redox control of renal function and hypertension. Antioxid Redox Signal 2008;10:2047-89. [PMID: 18821850 DOI: 10.1089/ars.2008.2034] [Cited by in Crossref: 106] [Cited by in F6Publishing: 106] [Article Influence: 8.2] [Reference Citation Analysis]
32 Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, Kobori H. Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol 2009;36:750-5. [PMID: 19298532 DOI: 10.1111/j.1440-1681.2009.05172.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
33 Kuru Karabas M, Ayhan M, Guney E, Serter M, Meteoglu I. The effect of pioglitazone on antioxidant levels and renal histopathology in streptozotocin-induced diabetic rats. ISRN Endocrinol 2013;2013:858690. [PMID: 23762597 DOI: 10.1155/2013/858690] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
34 Wang J, Shibayama Y, Kobori H, Liu Y, Kobara H, Masaki T, Wang Z, Nishiyama A. High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5. PLoS One 2017;12:e0185600. [PMID: 29053707 DOI: 10.1371/journal.pone.0185600] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]